BACKGROUND: MRI studies have demonstrated differential rates of atrophy in the entorhinal cortex and hippocampus during the prodromal phase of Alzheimer disease (AD). The current study was designed to determine whether a broader set of temporoparietal regions show differential rates of atrophy during the evolution of AD. METHODS: Sixteen regions of interest (ROIs) were analyzed on MRI scans obtained at baseline and follow-up in 66 subjects comprising three groups: controls = individuals who were cognitively normal at both baseline and follow-up; nonconverters = subjects with mild cognitive impairment (MCI) at both baseline and follow-up; converters had MCI at baseline but had progressed to AD at follow-up. RESULTS: Annualized percent change was analyzed with multivariate analysis of variance (MANOVA), covaried for age. The MANOVA demonstrated an effect of group (p = 0.004). Post hoc comparisons demonstrated greater rates of atrophy for converters vs nonconverters for six ROIs: hippocampus, entorhinal cortex, temporal pole, middle temporal gyrus, fusiform gyrus, and inferior temporal gyrus. Converters showed differentially greater rates of atrophy than controls in five of the same ROIs (and inferior parietal lobule). Rates of change in clinical status were correlated with the atrophy rates in these regions. Comparisons between controls and nonconverters demonstrated no differences. CONCLUSION: These results demonstrate that temporoparietal regions show differential rates of atrophy on MRI during prodromal Alzheimer disease (AD). MRI data correlate with measures of clinical severity and cognitive decline, suggesting the potential of these regions of interest as antemortem markers of prodromal AD.
BACKGROUND: MRI studies have demonstrated differential rates of atrophy in the entorhinal cortex and hippocampus during the prodromal phase of Alzheimer disease (AD). The current study was designed to determine whether a broader set of temporoparietal regions show differential rates of atrophy during the evolution of AD. METHODS: Sixteen regions of interest (ROIs) were analyzed on MRI scans obtained at baseline and follow-up in 66 subjects comprising three groups: controls = individuals who were cognitively normal at both baseline and follow-up; nonconverters = subjects with mild cognitive impairment (MCI) at both baseline and follow-up; converters had MCI at baseline but had progressed to AD at follow-up. RESULTS: Annualized percent change was analyzed with multivariate analysis of variance (MANOVA), covaried for age. The MANOVA demonstrated an effect of group (p = 0.004). Post hoc comparisons demonstrated greater rates of atrophy for converters vs nonconverters for six ROIs: hippocampus, entorhinal cortex, temporal pole, middle temporal gyrus, fusiform gyrus, and inferior temporal gyrus. Converters showed differentially greater rates of atrophy than controls in five of the same ROIs (and inferior parietal lobule). Rates of change in clinical status were correlated with the atrophy rates in these regions. Comparisons between controls and nonconverters demonstrated no differences. CONCLUSION: These results demonstrate that temporoparietal regions show differential rates of atrophy on MRI during prodromal Alzheimer disease (AD). MRI data correlate with measures of clinical severity and cognitive decline, suggesting the potential of these regions of interest as antemortem markers of prodromal AD.
Authors: R J Killiany; B T Hyman; T Gomez-Isla; M B Moss; R Kikinis; F Jolesz; R Tanzi; K Jones; M S Albert Journal: Neurology Date: 2002-04-23 Impact factor: 9.910
Authors: V A Cardenas; A T Du; D Hardin; F Ezekiel; P Weber; W J Jagust; H C Chui; N Schuff; M W Weiner Journal: Neurobiol Aging Date: 2003 Jul-Aug Impact factor: 4.673
Authors: R J Killiany; T Gomez-Isla; M Moss; R Kikinis; T Sandor; F Jolesz; R Tanzi; K Jones; B T Hyman; M S Albert Journal: Ann Neurol Date: 2000-04 Impact factor: 10.422
Authors: J L Whitwell; M M Shiung; S A Przybelski; S D Weigand; D S Knopman; B F Boeve; R C Petersen; C R Jack Journal: Neurology Date: 2007-09-26 Impact factor: 9.910
Authors: A T Du; N Schuff; J H Kramer; S Ganzer; X P Zhu; W J Jagust; B L Miller; B R Reed; D Mungas; K Yaffe; H C Chui; M W Weiner Journal: Neurology Date: 2004-02-10 Impact factor: 9.910
Authors: C R Jack; M M Shiung; J L Gunter; P C O'Brien; S D Weigand; D S Knopman; B F Boeve; R J Ivnik; G E Smith; R H Cha; E G Tangalos; R C Petersen Journal: Neurology Date: 2004-02-24 Impact factor: 9.910
Authors: Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox Journal: Proc Natl Acad Sci U S A Date: 2002-04-02 Impact factor: 11.205
Authors: Richard P Kline; Elizabeth Pirraglia; Hao Cheng; Susan De Santi; Yi Li; Michael Haile; Mony J de Leon; Alex Bekker Journal: Anesthesiology Date: 2012-03 Impact factor: 7.892
Authors: Jessica M Foley; David H Salat; Nikki H Stricker; Regina E McGlinchey; William P Milberg; Laura J Grande; Elizabeth C Leritz Journal: Am J Alzheimers Dis Other Demen Date: 2015-05-24 Impact factor: 2.035
Authors: Rahul S Desikan; Mert R Sabuncu; Nicholas J Schmansky; Martin Reuter; Howard J Cabral; Christopher P Hess; Michael W Weiner; Alessandro Biffi; Christopher D Anderson; Jonathan Rosand; David H Salat; Thomas L Kemper; Anders M Dale; Reisa A Sperling; Bruce Fischl Journal: PLoS One Date: 2010-09-23 Impact factor: 3.240